Lawrence Klein

Lawrence Klein

Net worth: 2 M $ as of 2024-03-30

41 year
Consumer Services
Finance
Health Technology

Profile

Lawrence O. Klein is on the board of Dyne Therapeutics, Inc. and Chief Operating & Business Officer at CRISPR Therapeutics AG. Dr. Klein previously occupied the position of Associate Partner at Mckinsey & Co. (Switzerland). Dr. Klein received a doctorate from Stanford University and an undergraduate degree from the University of Wisconsin.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-03-30 27,384 ( 0.03% ) 2 M $ 2024-03-30
2023-03-30 10,725 ( 0.01% ) 304 483 $ 2024-03-30
2023-06-06 1,225 ( 0.01% ) 35 966 $ 2024-03-30

Lawrence Klein active positions

Former positions of Lawrence Klein

CompaniesPositionEnd
Private Equity Investor 2024-01-31
JASPER THERAPEUTICS, INC. Director/Board Member 2023-06-19
DYNE THERAPEUTICS, INC. Director/Board Member 2023-05-23
Corporate Officer/Principal 2016-01-31
CRISPR THERAPEUTICS AG Chief Operating Officer -
See the detail of Lawrence Klein's experience

Training of Lawrence Klein

Stanford University Doctorate Degree
University of Wisconsin Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Lawrence Klein's experience

Connections

36

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies3
CRISPR THERAPEUTICS AG

Health Technology

DYNE THERAPEUTICS, INC.

Health Technology

JASPER THERAPEUTICS, INC.

Finance

Private companies2

Finance

Commercial Services

See company connections
  1. Stock Market
  2. Insiders
  3. Lawrence Klein